Last 29 quarters of trend data · Healthcare · Contract Research & Manufacturing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 26.69 | 23.11 | 23.36 | 38.80 | 36.75 | 23.13 | 99.64 | — | 78.62 | 70.17 | 96.66 | 135.25 | 30.09 | — | 57.02 | 447.75 | — | 18.94 | 44.52 | 49.23 | 45.29 |
| — | -0.1% | -76.6% | — | -53.3% | -67.0% | +3.1% | — | +161.3% | — | +69.5% | -69.8% | — | — | +28.1% | +809.6% | — | -71.0% | +10.3% | -68.4% | — | |
| P/S Ratio | 3.71 | 4.11 | 3.98 | 3.68 | 4.16 | 3.62 | 2.70 | 3.25 | 3.36 | 4.18 | 3.05 | 3.44 | 3.85 | 4.00 | 5.22 | 5.74 | 2.32 | 1.92 | 5.15 | 6.40 | 6.83 |
| — | +13.6% | +47.4% | +13.4% | +24.0% | -13.3% | -11.6% | -5.5% | -12.7% | +4.4% | -41.6% | -40.2% | +65.8% | +108.3% | +1.5% | -10.3% | -66.0% | -76.2% | -23.4% | -22.0% | -14.9% | |
| P/B Ratio | 7.57 | 7.29 | 7.68 | 6.63 | 8.34 | 8.19 | 6.21 | 7.98 | 9.63 | 10.14 | 7.99 | 7.95 | 10.76 | 11.16 | 12.75 | 14.03 | 6.67 | 3.15 | 8.63 | 9.44 | 11.24 |
| — | -11.0% | +23.6% | -17.0% | -13.4% | -19.2% | -22.2% | +0.5% | -10.5% | -9.1% | -37.3% | -43.4% | +61.3% | +254.2% | +47.8% | +48.6% | -40.7% | -77.3% | -33.3% | -36.8% | -26.5% | |
| P/FCF | 33.71 | 23.16 | 30.41 | — | 24.10 | 32.23 | 30.34 | 23.22 | — | 20.13 | 43.58 | — | 24.71 | — | — | — | 19.34 | 16.60 | 61.83 | 105.10 | 65.66 |
| — | -28.1% | +0.2% | — | — | +60.1% | -30.4% | — | — | — | — | — | +27.8% | — | — | — | -70.5% | -41.1% | +98.3% | +112.6% | -92.5% | |
| EV / EBITDA | 11.34 | 12.34 | 12.53 | 12.94 | 10.35 | 11.62 | 10.52 | 13.67 | 11.71 | 13.80 | 11.74 | 14.68 | 11.75 | 13.77 | 18.01 | 23.13 | 10.28 | 9.01 | 16.57 | 21.69 | 19.87 |
| — | +6.2% | +19.1% | -5.3% | -11.7% | -15.8% | -10.4% | -6.9% | -0.4% | +0.2% | -34.8% | -36.5% | +14.4% | +52.7% | +8.7% | +6.6% | -48.3% | -58.7% | -10.1% | -17.0% | -19.5% | |
| EV / EBIT | 16.53 | 15.30 | 15.62 | 19.65 | 16.53 | 14.47 | 21.81 | 51.32 | 17.37 | 20.22 | 24.66 | 26.03 | 15.71 | 38.28 | 28.36 | 49.20 | — | 13.68 | 28.90 | 34.88 | 27.94 |
| — | +5.7% | -28.4% | -61.7% | -4.8% | -28.4% | -11.6% | +97.1% | +10.6% | -47.2% | -13.0% | -47.1% | — | +179.9% | -1.9% | +41.0% | — | -64.1% | +9.7% | -43.8% | -83.4% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.5% | 55.6% | 55.4% | 51.4% | 54.7% | 57.0% | 56.6% | 53.2% | 56.6% | 55.4% | 55.2% | 51.2% | 58.0% | 55.5% | 54.7% | 50.5% | 56.3% | 54.7% | 56.4% | 54.4% | 55.5% |
| — | -2.4% | -2.2% | -3.3% | -3.5% | +3.0% | +2.5% | +3.9% | -2.4% | -0.2% | +1.0% | +1.3% | +3.0% | +1.4% | -3.1% | -7.1% | +1.4% | -1.5% | -1.2% | +0.1% | -0.1% | |
| Operating Margin | 33.8% | 35.0% | 33.2% | 30.9% | 44.9% | 35.7% | 30.0% | 22.4% | 30.0% | 28.2% | 27.8% | 21.4% | 33.5% | 28.9% | 24.8% | 15.1% | 23.9% | 25.4% | 26.8% | 22.6% | 27.5% |
| — | -2.1% | +10.6% | +38.0% | +49.4% | +26.6% | +8.2% | +4.6% | -10.4% | -2.5% | +12.1% | +41.7% | +40.2% | +13.8% | -7.7% | -33.1% | -13.1% | -12.5% | -13.7% | +3.4% | +14.0% | |
| Net Margin | 6.7% | 18.0% | 16.7% | 9.5% | 11.5% | 15.5% | 2.7% | -5.2% | 4.2% | 6.0% | 3.2% | 2.5% | 12.5% | -5.2% | 9.2% | 1.3% | -127.1% | 10.1% | 11.4% | 12.9% | 14.9% |
| — | +15.6% | +517.1% | +282.2% | +170.4% | +161.1% | -14.5% | -304.5% | -65.9% | +214.7% | -65.6% | +97.7% | +109.8% | -151.4% | -19.3% | -90.0% | -951.7% | -16.9% | -32.5% | +153.2% | +174.1% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 15.4% | 8.3% | 8.3% | 4.3% | 6.0% | 9.1% | 1.7% | -3.2% | 2.8% | 3.8% | 2.1% | 1.4% | 9.4% | -3.4% | 6.0% | 0.8% | -66.8% | 4.0% | 4.8% | 5.0% | 6.5% |
| — | -8.4% | +384.0% | +233.7% | +114.0% | +139.5% | -16.2% | -323.6% | -70.1% | +210.9% | -65.9% | +81.3% | +114.1% | -185.0% | +26.7% | -84.0% | -1131.9% | -22.8% | -44.7% | +111.8% | +167.4% | |
| ROA | 2.5% | 1.7% | 1.6% | 0.8% | 1.1% | 1.5% | 0.3% | -0.4% | 0.4% | 0.5% | 0.3% | 0.2% | 1.3% | -0.4% | 0.7% | 0.1% | -10.8% | 0.9% | 1.1% | 1.1% | 1.3% |
| — | +15.4% | +550.2% | +290.3% | +172.7% | +176.0% | -11.9% | -310.4% | -68.4% | +222.5% | -60.5% | +134.8% | +111.6% | -150.3% | -32.4% | -92.0% | -928.8% | -9.5% | -29.2% | +178.3% | +181.4% | |
| ROIC | 11.8% | 3.3% | 3.1% | 2.5% | 4.0% | 3.3% | 2.7% | 1.7% | 2.6% | 2.4% | 2.3% | 1.6% | 3.2% | 2.3% | 2.1% | 1.2% | 2.1% | 2.1% | 2.3% | 1.7% | 2.2% |
| — | -0.1% | +16.8% | +46.7% | +54.3% | +37.8% | +16.4% | +8.5% | -17.3% | +3.6% | +9.0% | +28.6% | +49.4% | +12.4% | -8.4% | -27.9% | -3.4% | -5.5% | -10.9% | +12.6% | +25.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 3.75 | 3.10 | 3.41 | 3.65 | 3.75 | 4.14 | 4.60 | 5.67 | 5.81 | 5.01 | 5.55 | 5.46 | 5.24 | 6.16 | 5.56 | 6.44 | 5.80 | 3.02 | 2.89 | 2.84 | 3.12 |
| — | -25.0% | -25.9% | -35.6% | -35.4% | -17.5% | -17.2% | +3.7% | +10.7% | -18.6% | -0.1% | -15.1% | -9.6% | +104.0% | +92.4% | +126.3% | +86.0% | -13.1% | -21.3% | -31.1% | -25.7% | |
| Debt / EBITDA | 4.28 | 15.58 | 16.18 | 19.33 | 13.48 | 16.32 | 19.03 | 23.98 | 18.44 | 19.08 | 20.12 | 25.07 | 16.08 | 20.36 | 22.64 | 31.88 | 21.03 | 18.46 | 16.94 | 20.39 | 17.48 |
| — | -4.5% | -15.0% | -19.4% | -26.9% | -14.5% | -5.4% | -4.3% | +14.7% | -6.3% | -11.1% | -21.4% | -23.5% | +10.3% | +33.6% | +56.3% | +20.3% | +4.4% | +2.1% | -10.8% | -18.7% | |
| Current Ratio | 2.46 | 3.13 | 2.80 | 2.82 | 2.46 | 2.38 | 2.47 | 2.46 | 2.75 | 2.88 | 2.93 | 3.20 | 2.42 | 2.59 | 2.73 | 1.54 | 0.81 | 3.00 | 2.81 | 2.58 | 2.15 |
| — | +31.5% | +13.2% | +14.8% | -10.8% | -17.3% | -15.8% | -23.2% | +14.0% | +11.3% | +7.5% | +107.8% | +196.5% | -13.8% | -2.8% | -40.4% | -62.0% | +19.0% | +4.1% | +8.6% | -4.2% | |
| Quick Ratio | 2.22 | 2.89 | 2.53 | 2.52 | 2.22 | 2.16 | 2.23 | 2.19 | 2.50 | 2.61 | 2.59 | 2.86 | 2.21 | 2.40 | 2.52 | 1.46 | 0.77 | 2.74 | 2.53 | 2.27 | 1.81 |
| — | +34.0% | +13.6% | +15.2% | -11.1% | -17.3% | -14.2% | -23.6% | +13.2% | +8.6% | +2.9% | +95.8% | +187.3% | -12.3% | -0.4% | -35.5% | -57.6% | +22.1% | +3.8% | +6.0% | -9.4% | |
| Interest Coverage | 1.95 | 3.45 | 3.27 | 2.23 | 3.01 | 2.86 | 1.46 | 0.64 | 2.10 | 2.03 | 1.37 | 1.26 | 2.54 | 1.01 | 2.12 | 1.19 | -10.73 | 2.79 | 4.43 | 5.35 | 4.76 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 29 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SHC stock.
Sotera Health Company's current P/E is 26.7x. The average P/E over the last 4 quarters is 30.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Sotera Health Company's current operating margin is 33.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Sotera Health Company's business trajectory between earnings reports.